Cargando…
New Trends and Therapies for Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is associated with an elevated risk of atherosclerosis. The finding of monogenic defects indicates higher atherosclerotic risk in comparison with hypercholesterolemia of other etiologies. However, in heterozygous FH, cardiovascular risk is heterogeneous and depends...
Autores principales: | Alnouri, Fahad, Santos, Raul D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696955/ https://www.ncbi.nlm.nih.gov/pubmed/36431115 http://dx.doi.org/10.3390/jcm11226638 |
Ejemplares similares
-
Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021) -
The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry
por: Alallaf, Faisal, et al.
Publicado: (2017) -
The genetics of familial hypercholesterolemia and emerging therapies
por: Vogt, Anja
Publicado: (2015) -
The promising novel therapies for familial hypercholesterolemia
por: Chen, Ruoyu, et al.
Publicado: (2022) -
Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)